Cubresa at the Third Annual MPIC Meeting in Nashville Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging As an industry sponsor of the 3rd Annual Midwest Preclinical Imaging Consortium (MPIC), we enjoyed meeting all the attendees while in Nashville at the meeting. We will be pleased to speak with you to show you how our NuPET™ in-bore PET…
10 am on Friday, May 15th in the Searle Seminar Room at the Robert H. Lurie Medical Research Center Cubresa held a seminar on Simultaneous Molecular & Functional Imaging with the Cubresa NuPET™ MR-compatible preclinical PET scanner at Northwestern University at 10 am on Friday, May 12th in the Searle Seminar Room at the Robert H. Lurie…
Come see Cubresa’s NuPET™ in Booth 125 at the ISMRM 2017 Annual Meeting & Exhibition in Honolulu Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging We certainly enjoyed our time at this year’s International Society for Magnetic Resonance in Medicine in Honolulu, April 22 to 27, 2017 where we showcased our NuPET™ in-bore PET scanner for existing pre-clinical…
Thank you for coming to see Cubresa’s NuPET™ at the EMIM 2017 Meeting & Exhibition in Cologne Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging This year’s European Molecular Imaging Meeting at Hörsaalgebäude University in Cologne, April 5 to 7, 2017 was a very successful showcase for our NuPET™ in-bore PET scanner for existing pre-clinical MRI systems. The…
Cubresa’s SPECT scanner was used to determine if a novel molecular label, TRV6001, in development for in vivo imaging of the BChE enzyme present in the brains of Alzheimer’s Disease patients follows the known distribution of the enzyme in animal models of the disease. Winnipeg, MB – November 22, 2016 – Cubresa Inc., a medical…

Simultaneous imaging with complementary modalities: PET & MRI If you missed our free webinar on Thursday, November 10th, you can request a link to view the recording, where you can learn how PET and MRI complement each other, and how one customer, Dr. Marty Pagel of the University of Arizona, is developing a dual-modality approach…

Dual-modality approach being developed by the University of Arizona uses Cubresa’s NuPET™ PET scanner and a dynamic MRI technique to more fully characterize cancerous tumors. Winnipeg, MB – September 1, 2016 – Cubresa Inc., a medical imaging company that develops and markets molecular imaging systems, today announced the successful installation of their compact PET scanner called NuPET™ for…

Cubresa to Exhibit at the WMIC 2016 Annual Congress & Exhibition in New York UPDATE: Congratulations to Patrick Chow of Bristol-Myers Squibb, on winning our custom-engraved Apple® iPad™ Pro in the booth on Saturday. Dr. Chow was selected at random from attendees who participated in our survey. Bookmark this page[1]To bookmark this page, press the Ctrl (PCs)…

Cubresa’s NuPET™ scanner enables simultaneous preclinical molecular & functional imaging. The PET (Positron Emission Tomography) scanner inserts into existing MRI (Magnetic Resonance Imaging) systems and can speed drug development and clarify disease mechanisms for biomedical researchers. Cancer researchers can better understand tumors using Cubresa’s NuPET™ PET scanner with an MRI to see and measure responses…

Cubresa’s NuPET™ scanner enables simultaneous preclinical molecular & functional imaging. The PET (Positron Emission Tomography) scanner inserts into existing MRI (Magnetic Resonance Imaging) systems and can speed drug development and clarify disease mechanisms for biomedical researchers. Winnipeg, MB – April 26, 2016 – A compact PET scanner called NuPET™ has been commercially released for simultaneous preclinical…
Cubresa to Exhibit at the WMIC 2016 Annual Congress & Exhibition in New York Come visit us in Booth 207 at the Jacob Javits Convention Center in New York, September 7 to 10, 2016. We will be showcasing our NuPET™ in-bore PET scanner for existing pre-clinical MRI systems. The NuPET scanner enables simultaneous PET and MR imaging within your existing…

Cubresa’s NuPET™ arrived at the SNMMI 2016 Annual Meeting & Exhibition in San Diego Reveal disease & therapeutic mechanisms with simultaneous molecular & functional imaging Would you like to be empowered with simultaneous multimodal molecular & functional preclinical imaging? Would you like to combine PET with the soft tissue contrast and functional imaging capabilities of MRI — at…

Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.